Practice
Specialties
Hygiene
Clinical
Business
Cases
Careers
Tariffs
Sign In
Endodontics
Oral & Maxillofacial Surgery
Orofacial Pain
Orthodontics
Pediatrics
Periodontics
Smile Design
Analgesics: Page 24
CEL-SCI licenses head/neck cancer drug for Croatia, Serbia
By
DrBicuspid.com staff writers
CEL-SCI has expanded its licensing agreement with Teva Pharmaceutical Industries for its cancer drug Multikine, CEL-SCI's investigational phase III drug for the treatment of head and neck cancer.
July 19, 2011
Do targeted cancer therapies have fewer oral side effects?
By
Donna Domino
Targeted cancer therapies are generally thought to have fewer oral complications and milder side effects than conventional cancer chemotherapy. But a lit review in
Oral Oncology
found that most studies involving these therapies do not focus enough on the potential oral complications, especially when combined with other treatments.
June 28, 2011
Syringe modification could reduce injection pain
By
DrBicuspid.com staff writers
A syringe modification, which promises reduced pain for dental injections, has won a major innovation award for its creators. The syringe cartridge works by reducing the acidity of the injection by mixing in a neutralizing liquid just before the injection is delivered.
June 14, 2011
CEL-SCI extends clinical trials for head/neck cancer drug
By
DrBicuspid.com staff writers
Pharmaceutical company CEL-SCI has begun phase III clinical trials for its immunotherapy drug Multikine in Hungary.
June 12, 2011
U.S. jury finds Novartis not liable for jaw disease
By
Reuters Health
NEW YORK (Reuters) - A U.S. federal jury found that the bisphosphonate drug Zometa made by Novartis Pharmaceuticals was not to blame for the osteonecrosis of the jaw developed by a Rhode Island man who died of cancer in 2005.
May 26, 2011
Bayer launches new aspirin for faster pain relief
By
DrBicuspid.com staff writers
Bayer HealthCare has introduced Bayer Advanced aspirin, which can relieve pain twice as fast as previous Bayer aspirin tablets, according to the company.
May 25, 2011
Herbs: The new antibiotics?
By
DrBicuspid.com staff writers
Indian wild plants may play a role in fighting bacterial and fungal infections in the mouths of oral cancer patients, according to new research.
May 24, 2011
Behavioral therapy better than hypnosis for dental anxiety
By
DrBicuspid.com staff writers
A recent study published in
Psychotherapy and Psychosomatics
examines alternatives to general anesthesia for patients who have dental anxiety. Cognitive behavioral treatment (CBT) was better than hypnosis among alternatives to general anesthesia for treating dental anxiety, the researchers found.
May 23, 2011
Cancer patients on bisphosphonates don't develop ONJ
By
Rabia Mughal
Cancer patients on zoledronic acid and chemotherapy combined with the antiangiogenic agent bevacizumab who underwent a dental exam before starting treatment did not develop osteonecrosis of the jaw (ONJ), according to a new study in the
Journal of the American Dental Association
.
May 19, 2011
Mother to sue VCU Dental Clinic for child's death
By
DrBicuspid.com staff writers
A mother whose 6-year-old boy died while under sedation at Virginia Commonwealth University (VCU) Dental Faculty Practice in Richmond last year will file a lawsuit against the school this week, according to a story by WTVR CBS 6 News
.
May 10, 2011
Pierrel introduces purer form of articaine
By
DrBicuspid.com staff writers
Pierrel Research USA, a subsidiary of Pierrel SpA, will officially launch its new Orabloc articaine product in the U.S. at the California Dental Association (CDA) spring meeting in Anaheim this week.
May 9, 2011
Study IDs root cause of local anesthetic-related NSDs
By
Rob Goszkowski
Dentists should consider not using 4% concentration anesthetics in the trigeminal area after a data analysis found that high-concentration formulations are the root cause of most neurosensory disturbances (NSDs), Danish researchers report in the
Journal of the American Dental Association
.
May 4, 2011
Previous Page
Page 24 of 43
Next Page